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It may be questioned whether people attending skin cancer and melanoma screening 
clinics are sufficiently aware of their own risk profile. In June 1993, 4,146 people 
were examined in Southern Limburg, the Netherlands, during a voluntary melanoma 
screening project. Positive screenees, Le. those with presumed malignancies or with 
distinct precursor lesions, attended early during the day rather than late. This indicates 
that people with cancerous or precancerous skin lesions are, on the whole, sufficiently 
concerned as to take maximum advantage of the screening opportunity. Our findings 
also imply that abundant provider time and staffing are necessary during the early 
hours of such screenings. (Key words: melanoma, screening, self-selection, skin can­
cer )
Reprints: M.J.M. de Rooij.
S creening for melanoma and other skin cancers is recommended 
and practised in many countries. Screening is especially wor­
thwhile for high risk groups. So far, skin cancer and melano­
ma screening programmes have been based on public education 
campaigns followed by free consultation. It may be questioned whe­
ther the general public is sufficiently capable of purposeful self- 
assessment [1-4]. Despite adequate precampaign educational mes­
sages, screening programmes produce large numbers of negative 
screenees. There is a risk of overtreatment, anxiety, and increased 
health system costs. Therefore, we need data to demonstrate that 
persons who voluntarily attend melanoma/skin cancer screenings 
are, on the whole, at risk for the disease.
In 1993 we conducted a number of free melanoma screening clinics in 
Southern Limburg, the Netherlands. The main aims of the project 
were to investigate: (1) the value of screening for melanoma only, ins­
tead of screening for skin cancer in general; and (2) the extra yield of  
total skin examination additional to examination o f  specific lesions 
the attendees are worried about. More or less fortuitously, we noticed 
that people with cancerous or precancerous lesions attended relatively 
early in the morning, and that the rate of trivial lesions increased 
during the day. The workload was highest during the morning ses­
sions and decreased in the afternoon. These observations may indicate 
that participants who appraise their lesions with accuracy, are maxi­
mally motivated to attend the screenings. In addition, our findings 
may have practical implications regarding staffing of the screening 
exercises. The present study was initiated to address these points.
Materials and methods
In June 1993 ten, free melanoma screening clinics were held in Sou­
thern Limburg, the Netherlands. The screenings took place over two 
consecutive Saturdays. All dermatologists in the region participated 
in this project. The area has a population of approximately 650,000. 
At each clinic, attendants were divided into three equal groups, the 
early and late comers at both ends, and an intermediate group. 
Because o f  the retrospective nature of the study we were unable to 
ascertain the precise time of first and last attendances in each group. 
All clinically suspicious malignancies were recorded. Diagnoses 
included were: melanoma, lentigo maligna, basal and squamous cell 
carcinoma, and B ow en’s disease. All patients with presumptive 
malignant lesions received a referral letter. Precursor states were 
divided into two groups: those with borderline lesions and those 
with more obvious disease. The attendants in the first group were 
advised to see a doctor in due course on their own initiative. The
persons in the latter category were given a letter of referral for their 
general physician to secure proper treatment at their earliest conve­
nience. Diagnoses included were actinic keratosis, dysplastic and 
congenital naevus, and sebaceus naevus. Persons with clinically sus­
picious skin cancer and those with clear evidence of a precursor 
state warranting referral, comprised the positive screenec group. 
Negative screenees were those with borderline precursor lesions and 
those with benign skin marks.
After 4 months and again after 10 months the screen-positive parti­
cipants were followed. To this end the positive screenees were 
contacted by letter or telephone, dermatologists were asked for treat­
ment and pathology particulars, and the Dutch national pathology 
data bank (PALGA) was scrutinized for cancerous and precancerous 
diagnoses among the positive screenees. Completeness o f  follow-up 
of positive screenees was 95%.
Statistical significance of differences between the groups was asses­
sed using the non-parametric test of Kruskal-Wallis. When appro­
priate, statistical significance of trends was tested using logistic 
regression.
Results
There were 4,146 attendants with evaluable records. O f these, 1,381 
were categorized as early-comers, 1,380 were in the intermediate 
group, and 1,385 were late-comers. Relatively more positive screenees 
came early, whereas innocuous lesions were more often seen late. In 
Table I the screenees are grouped by clinical diagnosis and according 
to time of presentation. More presumptive cancerous and distinct pre­
cursor lesions were seen early during the screenings (p = 0.03). This 
trend was observed during both screening days and was consistent at 
almost all screening locations. The total number of referrals (positive 
screenees, Le. presumptive malignant lesions and distinct precursor 
lesions combined) decreased from 190 in the early group to 139 in the 
intermediate group, and to 117 in the late group (p < 0.001 ).
Table I also presents the follow-up data of positive screenees. Histo­
logically confirmed melanomas and non-melanoma skin cancers are 
shown separately. More melanomas and non-melanoma skin cancers 
were found among the early-comers as compared with the later 
groups (p = 0.006). Numbers include melanoma in situ and carcino­
ma in situ. As for melanoma only, the trend o f  decreasing incident 
cases during the day did not reach statistical significance (p =  0.10). 
Small numbers, however, preclude meaningful statistical analysis. 
All but one melanomas were of favourable microstage (Breslow 
thickness < 1 mm).
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Table I. Particulars o f screenees according to time o f attendance
(percentages in brackets)
Time of attendance Significance
Early Interm ediate Late
n = 1,381 n ® 1,380 n ä  1,385
Clinical diagnosis
Malignant lesion 68 (4.9) 61 (4.4) 42 (3.0)
Precursor lesion,
distinct 122 (8.8) 78 (5,7) 75 (5.4)
Precursor lesion,
borderline 106 (7.7) 138 (10.0) 134 (9.7)
Benign lesion 1,085 (78,6) 1,103 (79.9) 1,134 (81.9) p = 0.03*
Histologic diagnosis
Melanoma 7 (0.5) 4 (0.3) 2 (0.1) p = 0.10**
Non-melanoma
skin cancer 20 (1.4) 14 (1.0) 8 (0.6) p = 0.03**
Total 27 (2.0) 18 (1.3) 10 (0.7) p = 0.006**
Fear of skin cancer 408 (29.5) 354 (25.7) 349 (25.2) p = 0.0l**
* Kruskal- Wallis rest. 
** Logistic regression.
shold, which causes a higher referral rate. If that were the case then 
the number of false-positive screenees would be highest among the 
early comers and the number of true-positive screenees (proved by 
histotogy) would be more or less equal in the three groups accor­
ding to time of attendance. In fact, the rate of true positives decrea­
sed steadily during the day. Moreover, fear o f  cancer was more 
often recorded by the early coiners than by the late comers. In pre­
vious skin cancer screening campaigns in the Netherlands we  
encountered very low false-negative results (three out of 1,551 per­
sons followed) [11]. These findings indicate that the trends reported 
herein are screenee-dependent and not screener-dependent.
We noticed that during the morning sessions more people per hour 
were attending than in the afternoon. Added to this, the rate o f  posi­
tive screenees was highest in the early hours. Screen-positive per­
sons need more thorough examination, they have to be advised and 
reassured, referral notes have to be written, et cetera. This has defi­
nite practical implications. One of the most fundamental prerequi­
sites o f  skin cancer and melanoma screening campaigns is the opti­
mal organization of the screens [12, 13]. High attendance rates and 
increased positive findings during the first hours of the screening 
necessitates abundant provider time, extra auxiliary personnel, and 
ample examination rooms. ■
Fear of having skin cancer was an important reason for attending 
the screens in 1,111 persons (26.8%). Early-comers admitted the 
fear of skin cancer more often than screenees in the intermediate 
and late groups {Table /; p = 0.01).
Discussion
Screening on the basis o f  self-selection appears to be a suitable 
method for the early detection of melanoma and non-melanoma skin 
cancer. How accurate self-screening is, depends largely on the 
appropriateness o f  precampaign public educational programmes. 
Promotional strategies should attract the proper target population. 
There is som e doubt about the ability o f  the general public to 
appraise skin lesions as risky |1, 2, 4]. This is not surprising since 
reliable interpretation of warning signs of melanoma may be extre­
mely difficult for even non-dermatologist physicians [5-71, and even 
for dermatologists (8, 9). Girasek noticed that attendees o f  skin can­
cer screening clinics were unable to attribute their high risk status to 
their symptoms [11. She also found (hat positive screenees were no 
more likely than negative screenees to seek medical attention of 
their own volition, had a screening opportunity not been offered. 
Likewise, Weinstoek emphasised that the screenee’s perception that 
a melanoma warning sign or risk factor is present, may be inaccura­
te [2]. On the other hand, there are literature data suggesting that 
high risk persons are, in general, sufficiently aware of their own risk 
profile [3, 8J.
Rather by chance we noticed that during a screening project in 1993 
relatively more malignancies were diagnosed during the early hours 
of the screenings. The workload was- highest during the morning 
sessions. These observations prompted us to conduct the present 
investigation. Our findings indicate that positive screenees are, on 
the whole, more seriously worried about their skin lesions than 
screen-negative persons. They apparently visit the screening location 
as soon as it suits them in order to take maximal advantage of the 
screening. Another interpretation might be that those individuals 
who get up early are at higher risk o f  developing skin cancer. This 
possibility seems most unlikely.
We also noticed that screening concentrating on melanoma, instead 
of skin cancer in general« increases the numbers of lesions suggesti­
ve of melanoma and dysplastic naevi [10). This implies that people 
attending in response to multimedia publicity efforts seem to be at 
appropriately high risk.
One may argue that at the beginning o f  the screening exercise der­
matologists display greater alertness or have a lower referral thre­
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